Clinical studies confirm that after three months of topical 1% propranolol gel treatment for superficial IH, patients’ plasma VEGF levels decrease significantly (p < 0.05), accompanied by marked clinical improvements such as lightening of the IH color and reduction in thickness (14). This evidence concerns the gene VEGFA and isolated hemihyperplasia.